Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06962956 · ClinicalTrials.gov registry record · Phase 1

Evaluating Gingivitis and Systemic Biomarkers

A Phase 1 study of Gingivitis, sponsored by Procter and Gamble.

Active
Registry status
Phase 1
Development phase
135
Enrollment target
1
Study location

NCT06962956 is a Phase 1 study of Gingivitis that is active but no longer recruiting, run by Procter and Gamble. The registered enrollment target is 135 participants, below the 231-participant average among 25 other Gingivitis trials with a reported enrollment target (42% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06962956, a Phase 1 study of Gingivitis, is active but no longer recruiting, sponsored by Procter and Gamble.

ACTIVE NOT RECRUITING
Registry status
Phase 1
Development phase
135 participants
Enrollment target
1
Study location

Study Summary

This exploratory study will consist of two parts: Phase 1 (sample collection/screening) and Phase 2 (sample collection/product efficacy testing). The purpose of Phase 1 is to understand the association of gingivitis to systemic biomarkers and to screen subjects for Phase 2. The purpose of Phase 2 is to assess the causal effect of oral hygiene intervention on gingivitis and systemic biomarkers.

Conditions Studied

Interventions

  • DRUG 0.76% Sodium Monofluorophosphate Dentifrice
  • DRUG 0.454% Stannous Fluoride Dentifrice

Study Locations (1)

Indiana

  • Salus Research - Fort Wayne

Trial Details

FieldValue
Enrollment Target 135 participants
Start Date 2025-04-30
Est. Completion 2025-10-31
Phase Phase 1

Sponsor

Procter and Gamble

70 total trials

What the Registry Record Tells You About NCT06962956

The ClinicalTrials.gov registry entry for NCT06962956 describes a study currently listed as active not recruiting, categorized as Phase 1. The registered enrollment target is 135 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 231-participant average among 25 other Gingivitis trials with a reported enrollment target (42% lower). The listed sponsor is Procter and Gamble, which has 70 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Gingivitis appearing as the primary indexed condition, and to 2 interventions - of which 0.76% Sodium Monofluorophosphate Dentifrice is the first listed.

NCT06962956 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.

Frequently Asked Questions

What is clinical trial NCT06962956 about?

NCT06962956 is a clinical study titled "Evaluating Gingivitis and Systemic Biomarkers". This exploratory study will consist of two parts: Phase 1 (sample collection/screening) and Phase 2 (sample collection/product efficacy testing). The purpose of Phase 1 is to understand the association of gingivitis to systemic biomarkers and to screen subjects for Phase 2. The purpose of Phase 2 is...

What is the current status of trial NCT06962956?

This trial is currently active not recruiting. It is a Phase 1 study. The enrollment target is 135 participants. The study started on 2025-04-30. Estimated completion is 2025-10-31.

What conditions does trial NCT06962956 study?

This clinical trial studies the following conditions: Gingivitis.

What interventions are being tested in trial NCT06962956?

The interventions under investigation include: 0.76% Sodium Monofluorophosphate Dentifrice (DRUG), 0.454% Stannous Fluoride Dentifrice (DRUG).

Who is sponsoring clinical trial NCT06962956?

This trial is sponsored by Procter and Gamble, which has 70 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06962956 being conducted?

This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Gingivitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.